Targeted News Service

NIH Contemplates Exclusive License for Cancer Diagnostic Technology
November 24, 2025

WASHINGTON, Nov. 24 (TNSFR) -- The U.S. Department of Health and Human Services National Institutes of Health has considered granting an Exclusive Patent License to BioncoDx LLC, a company organized in Delaware. This license would allow the company to commercialize patented inventions related to a non-invasive method for the diagnosis and prognosis of cancer.

The two child institutes involved in this process are the NIH's National Cancer Institute and the National Institute of . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your Affiliation	Government Newspaper / Media Business Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions or comments:

Click here for more information about our products

Existing Customer Login

Targeted News Service Document Request Form